Neoplasias relacionadas ao tabaco: análise de sobrevivência e risco de óbito de dados populacionais de Florianópolis, SC

Schneider, Ione Jayce Ceola; Schmidt, Tauana Prestes; Corrêa, Vanessa Pereira; Santos, Ana Maria Martins dos; Rocha, Bruna Vanti da; Garcia, Leandro Pereira; Ceccon, Roger Flores

doi:10.11606/s1518-8787.2022056003651

Cited by 4 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, only a few women diagnosed with BOTs are treated with chemotherapy due to the limited effects on BOTs, 40 although, women with serous BOTs, particularly women with extra‐ovarian disease, actually might have received chemotherapy in previous years due to their serous BOT diagnosis which could therefore explain myeloid leukemia as a treatment‐induced secondary malignancy due to chemotherapy. In addition, it is likely that shared risk factors as for example smoking 36 particularly for mucinous BOTs may also partly explain our findings of an increased risk of developing myeloid leukemia rather than just the chemotherapeutic treatment itself.…”

Section: Discussionmentioning

confidence: 96%

“… 15 , 16 , 17 Both the association between mucinous BOTs and lung and pancreatic cancer, respectively, are likely explained by shared risk factors such as smoking, which has been established especially for BOTs and ovarian cancer of mucinous histology 35 as well as for lung and pancreatic cancer. 36 The association between mucinous BOTs and pancreatic cancer might also be explained by shared genetics such as the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, 37 which is associated with both epithelial ovarian cancer and pancreatic cancer 15 and may also be related to BOTs. 34 Finally, mucinous BOTs are sometimes misclassified metastases of pancreatic cancer since metastases from pancreatic cancer on occasion can histologically mimic a mucinous BOT.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark

Hannibal

Baandrup

Hertzum‐Larsen

et al. 2022

Intl Journal of Cancer

View full text Add to dashboard Cite

Evidence regarding cancer risk after borderline ovarian tumors (BOTs) is limited. We conducted a nationwide cohort study examining the incidence of nonovarian cancers in women with serous or mucinous BOTs compared with the general female population with up to 41 years of follow‐up. Through the nationwide Pathology Registry, we identified nearly 5000 women with BOTs (2506 serous and 2493 mucinous) in Denmark, 1978 to 2018. We computed standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) as relative risk estimates of specific nonovarian cancers. Compared with general female population rates, women with serous BOTs had increased rates of particularly malignant melanoma (SIR = 1.9; 95% CI: 1.3‐2.6), thyroid cancer (SIR = 3.0; 95% CI: 1.4‐5.4) and myeloid leukemia (SIR = 3.2; 95% CI: 1.5‐5.8), and women with mucinous BOTs had elevated rates of lung cancer (SIR = 1.7; 95% CI: 1.3‐2.1), pancreatic cancer (SIR = 1.9; 95% CI: 1.2‐2.9) and myeloid leukemia (SIR = 2.3; 95% CI: 0.9‐4.7). We found no convincing association with neither breast nor colorectal cancer in women with BOTs. This is the first large nationwide study showing that women with specific types of BOTs have increased risks of several nonovarian cancers, likely due to some shared risk factors or genetic characteristics.

show abstract

Section: Discussionmentioning

confidence: 96%

Section: Discussionmentioning

confidence: 99%

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark

Hannibal

Baandrup

Hertzum‐Larsen

et al. 2022

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden

Dobilas,

Jansåker,

et al. 2023

BMC Cancer

View full text Add to dashboard Cite

Background Associations between different cancer types are known. The affirmation of the risk for non-ovarian cancer after ovarian borderline tumors (BOT) is, however, sparse. Aim To analyze the risk of subsequent or simultaneous cancers in women with BOTs compared with the general female Swedish population. Methods An open cohort study (1995–2018) was conducted where a diagnosis of BOTs as well as subsequent or simultaneous cancer diagnoses were obtained from the Swedish Cancer Register and matched to the Total Population Register. Each woman with BOT was followed until non-ovarian cancer, death or emigration and could only be included once for the outcome. Standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) for specific non-ovarian cancers were analyzed. Results The 4998 women with serous and mucinous BOTs were diagnosed during 1995–2018 with a mean age of 55.7 years (SD 16.0) at diagnosis. Compared with the general female population, women with BOTs had increased risks for non-ovarian cancer in colon (SIR = 2.5; 95% CI 2.0–3.1), rectum (SIR = 1.7; 95% CI 1.1–2.5), small intestine (SIR = 5.0; 95% CI 2.3–9.5), cervix (SIR = 2.5; 95% CI 1.4–4.2), endometrium (SIR = 2.4; 95% CI 1.9–3.1), pancreas (SIR = 2.3; 95% CI 1.4–3.5), upper aerodigestive tract (SIR = 2.2; 95% CI 1.2–3.8), lung (SIR = 1.8; 95% CI 1.4–2.3), kidney (SIR = 2.3; 95% CI 1.4–3.7) and bladder (SIR = 1.8; 95% CI 1.1–2.8). Among women with serous BOTs, the risk of thyroid gland cancer (SIR = 3.1; 95% CI 1.2–6.4) was also increased. Lung and pancreas cancer showed increased risks more than 1 year after a diagnosis of BOT. Conclusions This Swedish population-based study demonstrated an increased risk of multiple malignancies including lung and pancreatic cancers beyond the first year of diagnosis in patients with borderline ovarian tumors (BOTs), suggesting a potential shared etiology.

show abstract

Efeito Da Auriculoterapia Associada a Terapia De Reposição De Nicotina E Terapia Cognitivo Comportamental Nos Sintomas De Abstinência Em Pacientes Tabagistas Em Uma Unidade Básica De Saúde Do Distrito Federal: Série De Casos

Carvalho,

Giomo,

Ohofugi

2024

Rev. Contemp.

View full text Add to dashboard Cite

Objetivo: analisar a influência da Auriculoterapia, nos sintomas de abstinência dos pacientes tabagistas que participam do grupo antitabagismo de uma Unidade Básica de Saúde do Plano Piloto de Brasília-DF. Métodos: Trata-se de um estudo descritivo, sem grupo controle, de caráter narrativo e reflexivo, série de casos, com pacientes que iniciaram a participação no grupo de tratamento antitabagismo de uma Unidade Básica de Saúde no Distrito Federal. Houve a utilização de um protocolo de associação entre auriculoterapia, Terapia Cognitivo Comportamental e Terapia de Reposição de Nicotina com frequência de uma vez por semana durante oito semanas. A realização da análise ocorreu através do programa Statistical Package for the Social Sciences. A descrição dos dados aconteceu por meio de percentuais, frequências relativas e absolutas ou como média e desvio padrão, além de correlações, a depender do tipo de variável. Houve a utilização do teste de Wilcoxon para uma amostra. Resultados: Participaram do estudo dezessete pacientes, apenas dois concluíram o número total de sessões do protocolo. Em relação aos participantes concluintes, ocorreu um aumento nos escores da Escala Hospitalar de Ansiedade e Depressão em 27,27%. Além de redução da pontuação referente a Escala Visual Analógica de Fissura em 62,5% e 100%, quanto aos demais participantes esta foi de 29,41%. Foram registrados 15 relatos relacionados a eventos adversos, que incluíram leve dor e irritação local. Conclusão: A auriculoterapia, neste protocolo, apresentou um efeito significativo em relação a redução da intensidade da fissura, apesar das limitações apresentadas pelo estudo, além de ser um método seguro.

show abstract

Neoplasias relacionadas ao tabaco: análise de sobrevivência e risco de óbito de dados populacionais de Florianópolis, SC

Cited by 4 publications

References 22 publications

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark

Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden

Efeito Da Auriculoterapia Associada a Terapia De Reposição De Nicotina E Terapia Cognitivo Comportamental Nos Sintomas De Abstinência Em Pacientes Tabagistas Em Uma Unidade Básica De Saúde Do Distrito Federal: Série De Casos

Contact Info

Product

Resources

About